Hepatic involvement in light chain amyloidosis: analysis of 130 patients and predictors of hepatic response and survival
Matthew J. Rees(Mayo Clinic), Eli Muchtar(Mayo Clinic), David Dingli, Francis K. Buadi, Morie A. Gertz(Medical University of South Carolina), Binoy Yohannan(Mayo Clinic in Arizona), Prashant Kapoor, Moritz Binder(Mayo Clinic in Arizona), Nadia Toumeh(Mayo Clinic in Arizona), Rahma Warsame, Suheil Albert Atallah‐Yunes(Mayo Clinic in Arizona), S. Vincent Rajkumar(WinnMed), Wilson I. Gonsalves(Mayo Clinic in Arizona), Taxiarchis Kourelis(Mayo Clinic in Arizona), Nelson Leung(Mayo Clinic in Arizona), Suzanne R. Hayman, Angela Dispenzieri(Mayo Clinic), Shaji Kumar(Mayo Clinic in Arizona), Joselle Cook(Mayo Clinic in Arizona)
Cited by 8
Related Papers
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k